TERF2IP and cancer: Indeed, several human cancer patients have been found to harbor nonsense or deletion mutations right before CT domain of RAP1 (Supplementary Fig. 5)59,60, which could generate a RAP1 mutant which is unable to interact with these repair proteins and thus affect disease progression and response to chemotherapy.